Related Experiment Videos
Relapsing polychondritis.
1Ronald O. Perelman Department of Dermatology, New York University, USA.
Dermatology Online Journal
|November 5, 2003
Summary
Relapsing polychondritis involves recurrent inflammation and destruction of cartilage, particularly in the ears and respiratory tract. Autoimmunity against type II collagen drives this chronic condition, requiring anti-inflammatory treatments.
Area of Science:
- Rheumatology
- Immunology
- Pathology
Background:
- Relapsing polychondritis (RP) is a rare autoimmune disorder characterized by episodic inflammation and destruction of cartilaginous structures.
- The condition typically affects the ears, nose, eyes, and respiratory tract, leading to significant morbidity.
- Autoimmunity against type II collagen is implicated as a key pathogenic mechanism in RP.
Observation:
- A 57-year-old male presented with a two-year history of recurrent ear swelling (excluding earlobes) and migratory joint pain.
- Ear biopsy revealed perichondrial inflammation with lymphocytes, plasma cells, and neutrophils, alongside acellular foci in the cartilage.
Findings:
- Histopathological findings are consistent with relapsing polychondritis, demonstrating inflammatory infiltration and cartilage degeneration.
- The patient's presentation highlights the characteristic cartilaginous involvement and autoimmune basis of the disease.
Implications:
- Early diagnosis and management of relapsing polychondritis are crucial due to its potential for severe, life-threatening complications.
- Treatment strategies focus on anti-inflammatory and anti-neutrophilic agents, with prognosis dependent on organ system involvement and therapeutic response.
- Further research into the specific autoimmune targets and therapeutic interventions for RP is warranted.